Immune checkpoint binding assays for drug screening are essential tools in evaluating how candidate molecules interact with targets like PD-1, CTLA-4, and LAG-3. Creative Biolabs offers ligand binding, cell-based, and functional reporter gene assays to assess binding affinity, inhibition, and immunomodulatory effects. These assays help identify promising immune checkpoint inhibitors and guide their progression through preclinical development.
Last Edited by cailynn johnson on Aug 06, 2025 10:51 PM
